Page last updated: 2024-08-18

fluorodeoxyuridylate and Body Weight

fluorodeoxyuridylate has been researched along with Body Weight in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braakhuis, BJ; De Jong, M; Peters, GJ; Pinedo, HM; Smid, K; Van der Wilt, CL1
Fujimaki, M; Katuyama, S; Kuroki, Y; Okamoto, M; Sakamoto, T; Tazawa, K; Yamashita, I1
Anderson, J; Gmeiner, WH; Kolar, C; Kolath, J; Lawson, T; Liu, J; Skradis, A; Talmadge, J1
Hironaga, K; Kawaguchi, Y; Nagayama, S; Yamaguchi, S; Yamamoto, A; Yoshisue, K1
Fernandes, DJ; Klubes, P1

Other Studies

5 other study(ies) available for fluorodeoxyuridylate and Body Weight

ArticleYear
Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: potentiating or reversing effect?
    International journal of cancer, 1995, May-29, Volume: 61, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Division; Female; Fluorodeoxyuridylate; Fluorouracil; Humans; Leucovorin; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1995
Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose.
    Clinical & experimental metastasis, 1997, Volume: 15, Issue:3

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Combinations; Female; Floxuridine; Fluorodeoxyuridylate; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tegafur; Uracil

1997
Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Nucleosides & nucleotides, 1999, Volume: 18, Issue:8

    Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biotransformation; Body Weight; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fibroblasts; Fluorodeoxyuridylate; Fluorouracil; Half-Life; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Orotate Phosphoribosyltransferase; Prodrugs; Thymidine Kinase; Thymidylate Synthase; Tumor Cells, Cultured

1999
Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colon; Diarrhea; Digestive System; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Fluorodeoxyuridylate; Fluorouracil; Ileum; Male; Oxonic Acid; Pyridines; Rats; Tegafur; Thymidylate Synthase

2000
A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Cancer research, 1979, Volume: 39, Issue:4

    Topics: Animals; Body Weight; Bone Marrow; Cyclophosphamide; DNA, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fluorodeoxyuridylate; Fluorouracil; Leukemia L1210; Male; Mice; Mice, Inbred Strains

1979